A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
Clinical trial NCT04867616 · COMPLETED
Trial details
- NCT number
- NCT04867616
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2024-05-24
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.